Ivermectin Dosage Guide: Complete Safety & Usage Instructions

Introduction

Ivermectin is a widely prescribed antiparasitic medication that has been used safely for decades to treat various parasitic infections in humans. Understanding the proper ivermectin dosage guide is crucial for ensuring effective treatment while minimizing potential side effects. This medication works by paralyzing and killing parasites, making it an essential treatment option for conditions such as onchocerciasis (river blindness), strongyloidiasis, scabies, and other parasitic infections. Whether you've been prescribed ivermectin for intestinal parasites or skin conditions caused by parasites, knowing the correct dosage and administration guidelines is fundamental to achieving optimal therapeutic outcomes. This comprehensive guide provides detailed information about ivermectin dosing protocols, safety considerations, and practical usage instructions to help patients and healthcare providers make informed treatment decisions. At SafeRxPills, we prioritize patient safety and education, ensuring you have access to accurate, evidence-based information about this important antiparasitic medication.

What is Ivermectin?

Ivermectin is an FDA-approved antiparasitic medication that belongs to a class of drugs known as anthelmintics. Originally discovered in the 1970s, ivermectin has become one of the most important antiparasitic medications in modern medicine, earning its discoverers the Nobel Prize in Physiology or Medicine in 2015. The medication is derived from avermectins, naturally occurring compounds produced by the soil bacterium Streptomyces avermitilis.

Ivermectin is primarily used to treat infections caused by various parasites, including roundworms, threadworms, and ectoparasites like scabies mites and lice. The World Health Organization includes ivermectin on its List of Essential Medicines, recognizing its critical role in treating and preventing parasitic diseases, particularly in developing countries where parasitic infections remain prevalent. In humans, ivermectin is available in oral tablet form and topical formulations, each designed for specific therapeutic applications.

The medication's effectiveness stems from its unique mechanism of action against parasites, which is selectively toxic to invertebrates while maintaining a high safety profile in mammals when used at recommended dosages. Ivermectin has proven particularly valuable in mass drug administration programs aimed at eliminating diseases like river blindness and lymphatic filariasis in endemic regions. Beyond its established antiparasitic uses, ivermectin continues to be studied for various applications, though patients should only use it for FDA-approved indications under proper medical supervision.

For patients seeking reliable access to quality antiparasitic medications, SafeRxPills offers Ivermectin 12mg and other formulations with proper pharmaceutical standards and guidance.

How Does Ivermectin Work?

Ivermectin's antiparasitic action operates through a sophisticated mechanism that specifically targets invertebrate nerve and muscle cells. The medication works by binding selectively to glutamate-gated chloride ion channels found in invertebrate nerve and muscle cells. This binding causes an influx of chloride ions into the cells, leading to hyperpolarization of the cell membrane. The result is paralysis and death of the parasite, effectively eliminating the infection from the body.

What makes ivermectin particularly effective is its selectivity for invertebrate neurotransmitter systems. In parasites, glutamate-gated chloride channels are widespread throughout the nervous system. When ivermectin binds to these channels, it causes prolonged opening, resulting in continuous chloride ion influx. This disrupts normal neural transmission in the parasite, preventing movement, feeding, and reproduction. The paralyzed parasites are then cleared from the body through natural excretion processes.

The medication also affects parasites by binding to other chloride channels, including those gated by gamma-aminobutyric acid (GABA). While mammals also have GABA receptors, ivermectin does not readily cross the blood-brain barrier in humans at therapeutic doses, which explains its favorable safety profile. The blood-brain barrier effectively protects the mammalian central nervous system from ivermectin's effects, limiting its action primarily to peripheral sites where parasites reside.

Different parasites are susceptible to ivermectin at various stages of their life cycles. For some parasites like the microfilariae of Onchocerca volvulus (which causes river blindness), ivermectin is highly effective against the larval stages. For intestinal parasites like Strongyloides stercoralis, the medication affects adult worms and larvae in the tissues. The medication's pharmacokinetics involve absorption in the gastrointestinal tract, distribution throughout body tissues where parasites typically reside, and elimination primarily through feces.

The onset of action varies depending on the type of parasitic infection being treated. For some conditions, patients may notice improvement within days, while complete eradication of certain parasites may take weeks. Understanding this mechanism helps explain why proper dosing according to the ivermectin dosage guide is essential—insufficient doses may not achieve adequate parasite kill, while excessive doses increase the risk of adverse effects without additional therapeutic benefit.

Benefits of Ivermectin

Ivermectin offers numerous therapeutic benefits that have made it an indispensable medication in treating parasitic infections worldwide. The primary benefit is its broad-spectrum antiparasitic activity, effectively treating multiple types of parasitic infections with a single medication. This versatility makes ivermectin valuable for treating onchocerciasis, strongyloidiasis, scabies, head lice, and various other parasitic conditions, reducing the need for multiple different medications.

One of the most significant advantages of ivermectin is its excellent safety profile when used according to proper dosing guidelines. Decades of clinical use and extensive safety data demonstrate that ivermectin is generally well-tolerated by most patients, with serious adverse effects being rare when the medication is used appropriately. This favorable safety profile has enabled mass drug administration programs in endemic areas, where millions of doses have been safely distributed to prevent and control parasitic diseases.

The convenience of ivermectin treatment is another major benefit. For many parasitic infections, ivermectin can be administered as a single dose or a short course of treatment, improving patient compliance compared to medications requiring prolonged treatment regimens. This single-dose efficacy is particularly valuable in resource-limited settings and for patients who may have difficulty adhering to complex medication schedules.

Ivermectin has demonstrated remarkable effectiveness in preventing blindness caused by onchocerciasis (river blindness). Regular community-wide treatment with ivermectin has led to dramatic reductions in disease prevalence and has eliminated onchocerciasis as a public health problem in several countries. Similarly, ivermectin has proven highly effective for treating strongyloidiasis, a potentially life-threatening infection in immunocompromised patients that can be difficult to treat with other medications.

For scabies infestations, ivermectin offers particular advantages over topical treatments. The oral administration ensures treatment reaches all affected areas, including hard-to-reach locations, and eliminates the need for whole-body application of topical agents. This makes treatment more convenient and often more effective, especially in cases of crusted (Norwegian) scabies or in institutional outbreaks where simultaneous treatment of multiple individuals is necessary.

The medication's impact on global health cannot be overstated. Ivermectin has been instrumental in disease control and elimination programs, significantly reducing the burden of neglected tropical diseases in affected populations. Its affordability and ease of administration have made it accessible to vulnerable populations in developing countries, where parasitic infections contribute substantially to morbidity and economic burden.

SafeRxPills provides access to quality Ivermectin 6mg formulations, ensuring patients worldwide can access this essential antiparasitic medication with proper guidance and pharmaceutical quality standards.

Side Effects & Precautions

While ivermectin is generally well-tolerated, understanding potential side effects and necessary precautions is essential for safe use. Being aware of possible adverse reactions helps patients recognize when to seek medical attention and enables healthcare providers to monitor treatment appropriately.

Common Side Effects

Most side effects associated with ivermectin are mild to moderate and resolve without specific treatment. Common side effects include dizziness, nausea, diarrhea, and mild skin rash. Some patients experience fatigue, abdominal pain, or loss of appetite during treatment. These effects typically occur within the first few days of treatment and subside as the body adjusts to the medication.

Headache is another frequently reported side effect, ranging from mild to moderate intensity. Patients may also experience muscle or joint pain, particularly when treating infections with high parasite loads, as the dying parasites trigger inflammatory responses. Pruritus (itching) can occur, especially in patients being treated for filarial infections, resulting from the body's immune response to dead or dying microfilariae rather than a direct effect of the medication itself.

In patients being treated for onchocerciasis, a phenomenon known as Mazzotti reaction can occur. This reaction results from the rapid death of microfilariae and manifests as fever, rash, itching, swelling, enlarged lymph nodes, and joint pain. While uncomfortable, these reactions typically indicate that the medication is working effectively. Healthcare providers can manage these symptoms with supportive care and anti-inflammatory medications when necessary.

Serious Precautions

Certain populations require special consideration when using ivermectin. Patients with a history of conditions affecting the blood-brain barrier should exercise caution, as compromised barrier function may allow increased ivermectin penetration into the central nervous system. This includes patients with meningitis or trypanosomiasis affecting the central nervous system.

Pregnant and breastfeeding women should use ivermectin only when clearly necessary and under close medical supervision. While animal studies have not demonstrated significant teratogenic effects, human data are limited. The medication is excreted in breast milk, though concentrations are generally low. Healthcare providers must weigh potential benefits against possible risks when considering ivermectin use in these populations.

Patients with liver disease may require dosage adjustments or closer monitoring, as hepatic function affects ivermectin metabolism. Similarly, individuals with severe asthma or those taking medications that affect the blood-brain barrier (such as valproic acid) should inform their healthcare provider before starting ivermectin treatment.

Severe adverse reactions, while rare, can include severe skin reactions (Stevens-Johnson syndrome), hepatitis, and neurological effects such as seizures or encephalopathy. These typically occur in patients with underlying risk factors or those taking higher-than-recommended doses. Any signs of serious adverse reactions—including severe rash, jaundice, confusion, seizures, or difficulty breathing—require immediate medical attention.

Drug interactions should also be considered. Ivermectin may interact with warfarin, increasing anticoagulant effects. Concurrent use with other medications that affect GABA receptors or the blood-brain barrier requires careful evaluation. Patients should provide their healthcare provider with a complete list of medications, supplements, and herbal products they are taking to identify potential interactions.

Dosage & Usage Guidelines

Proper dosing of ivermectin is critical for achieving therapeutic success while minimizing adverse effects. The ivermectin dosage guide varies based on the specific parasitic infection being treated, patient weight, and individual medical factors. All dosing should be determined by a qualified healthcare provider based on accurate diagnosis and patient-specific considerations.

Standard Oral Medications

For most parasitic infections, ivermectin dosage is calculated based on body weight, typically expressed as micrograms per kilogram (mcg/kg). The standard dose for many conditions is approximately 150-200 mcg/kg of body weight, taken as a single oral dose on an empty stomach with water. Taking the medication on an empty stomach enhances absorption and effectiveness.

For strongyloidiasis (intestinal threadworm infection), the typical dose is 200 mcg/kg as a single oral dose. In immunocompromised patients or those with disseminated strongyloidiasis, repeated doses or prolonged treatment courses may be necessary. Follow-up stool examinations are essential to confirm parasite eradication, as repeated treatment may be required in some cases.

Onchocerciasis (river blindness) treatment typically involves a single oral dose of 150 mcg/kg, repeated every 6 to 12 months depending on the endemic area and disease control program protocols. This dosing schedule effectively suppresses microfilariae production and prevents disease progression while maintaining safety through spaced dosing intervals.

For scabies treatment, a single dose of 200 mcg/kg is often effective for uncomplicated cases. A second dose taken 7-14 days after the initial dose may be recommended to ensure eradication, as ivermectin may not kill all eggs, and the second dose targets newly hatched mites. In cases of crusted scabies, more intensive treatment regimens with multiple doses may be necessary.

Head lice infestations typically respond to a single 200 mcg/kg dose, with a repeat dose 7-10 days later to eliminate any lice that emerged from eggs after the initial treatment. This two-dose regimen has demonstrated high cure rates and offers a convenient alternative to topical pediculicides.

Alternative Treatments

While oral ivermectin is the primary formulation for systemic parasitic infections, topical ivermectin preparations are available for certain conditions. Topical ivermectin lotion (0.5%) is FDA-approved for treating head lice and offers a single-application treatment option. This formulation provides local antiparasitic action with minimal systemic absorption.

For rosacea, a different topical ivermectin formulation (1% cream) has been approved, though this represents a distinct indication from antiparasitic use. Patients should ensure they receive the appropriate formulation for their specific condition, as different preparations are not interchangeable.

In cases where ivermectin is contraindicated or unavailable, alternative antiparasitic medications may be considered depending on the specific infection. For strongyloidiasis, albendazole may be used as an alternative, though it is generally considered less effective than ivermectin. For scabies, topical permethrin cream remains a standard treatment option, particularly in populations where oral ivermectin may pose greater risks.

SafeRxPills offers Ivermectin 3mg for pediatric or lower-dose requirements, providing flexibility in achieving appropriate weight-based dosing for different patients.

Important Usage Guidelines

Ivermectin tablets should be taken with a full glass of water on an empty stomach, at least one hour before or two hours after a meal. This timing optimizes drug absorption and enhances therapeutic effectiveness. Patients should swallow tablets whole without crushing or chewing them, as this ensures proper medication release and absorption.

Weight-based dosing requires accurate body weight measurement for proper calculation. Healthcare providers use standardized dosing tables that correlate body weight ranges with appropriate tablet strengths and quantities. Patients should never adjust their dose without medical guidance, as both underdosing and overdosing can lead to treatment failure or increased adverse effects.

For parasitic infections treated with multiple doses, maintaining the prescribed dosing schedule is crucial. Missing doses or extending intervals beyond recommendations may reduce treatment effectiveness and allow parasites to survive, potentially leading to treatment failure or drug resistance development.

Patients should avoid alcohol consumption during ivermectin treatment and for at least 24 hours afterward, as alcohol may increase the risk of neurological side effects. Additionally, activities requiring alertness, such as driving or operating machinery, should be approached cautiously if dizziness occurs, particularly after the first dose.

Proper storage of ivermectin is essential for maintaining medication stability. Tablets should be kept in their original packaging at room temperature, away from moisture, heat, and direct light. The medication should be kept out of reach of children and pets, as accidental ingestion can cause serious toxicity.

When to See a Doctor

Knowing when to consult a healthcare provider is essential for safe and effective ivermectin treatment. Medical supervision ensures proper diagnosis, appropriate dosing, and monitoring for potential complications or treatment failure.

Initial Consultation Indicators

Before starting ivermectin treatment, consultation with a healthcare provider is mandatory. Self-diagnosis and self-medication with antiparasitic drugs can lead to inappropriate treatment, missed diagnoses, and potential harm. Patients experiencing symptoms suggestive of parasitic infection—such as persistent itching, skin rashes, gastrointestinal disturbances, or unexplained eosinophilia on blood tests—should seek medical evaluation.

A proper diagnostic workup typically includes physical examination, patient history regarding travel or exposure risks, and specific diagnostic tests appropriate for the suspected parasitic infection. For intestinal parasites, stool examinations may be necessary. For filarial infections, blood tests or skin snips may be required. Accurate diagnosis ensures that ivermectin is the appropriate treatment and allows for proper dosing based on the specific parasite involved.

Patients with pre-existing medical conditions, particularly liver disease, neurological disorders, or compromised immune function, require comprehensive medical assessment before ivermectin use. Healthcare providers need to evaluate potential contraindications, assess risk factors for adverse effects, and determine whether dose adjustments or alternative treatments are necessary.

Emergency Situations

Certain symptoms during or after ivermectin treatment require immediate medical attention. Severe allergic reactions, though rare, constitute medical emergencies. Signs of anaphylaxis include difficulty breathing, throat swelling, severe dizziness, rapid heartbeat, or loss of consciousness. These symptoms require immediate emergency care.

Neurological symptoms such as seizures, confusion, altered consciousness, or severe unsteadiness warrant urgent medical evaluation. While rare at therapeutic doses, these symptoms could indicate severe adverse reactions or underlying conditions that increase susceptibility to ivermectin's central nervous system effects.

Severe skin reactions, including widespread rash with blistering, peeling skin, or mucosal involvement, require immediate medical assessment. These could indicate serious conditions like Stevens-Johnson syndrome or toxic epidermal necrolysis, which, though extremely rare with ivermectin, require urgent intervention.

Signs of severe Mazzotti reaction in patients being treated for onchocerciasis—including high fever, severe edema, hypotension, or signs of potential eye involvement—necessitate prompt medical evaluation. While most Mazzotti reactions are manageable, severe reactions require supportive care and symptom management.

Ongoing Medical Monitoring

Follow-up care is an essential component of parasitic infection treatment. After completing ivermectin treatment, patients typically require follow-up examinations to confirm parasite eradication. The timing and type of follow-up testing depend on the specific infection treated. For strongyloidiasis, repeat stool examinations may be performed several weeks after treatment to verify cure.

Patients who do not experience symptom improvement within the expected timeframe should return to their healthcare provider. Treatment failure may indicate drug-resistant parasites, incorrect diagnosis, reinfection, or inadequate dosing. In such cases, alternative treatments or repeated courses may be necessary.

Long-term monitoring may be appropriate for certain populations. Immunocompromised patients treated for strongyloidiasis may require prolonged surveillance to detect potential recurrence. Patients in endemic areas receiving periodic ivermectin for onchocerciasis control require ongoing participation in mass drug administration programs with regular monitoring for disease progression.

Any new or worsening symptoms after starting ivermectin treatment should prompt medical consultation. While many side effects are self-limited, persistent or severe symptoms may require intervention or treatment modification. Open communication with healthcare providers ensures optimal treatment outcomes and patient safety.

Lifestyle Modifications and Complementary Approaches

While ivermectin effectively treats parasitic infections, complementary lifestyle modifications and preventive measures enhance treatment success and reduce reinfection risk. These approaches work synergistically with pharmacological treatment to optimize outcomes and prevent future infections.

Dietary and Exercise Interventions

Proper nutrition supports immune function and recovery from parasitic infections. A balanced diet rich in fruits, vegetables, lean proteins, and whole grains provides essential nutrients that support the body's natural defenses. Adequate protein intake is particularly important during recovery, as it supports tissue repair and immune cell production.

Certain dietary considerations may be relevant during parasitic infection treatment. Maintaining good hydration supports medication absorption and helps the body eliminate dead parasites and metabolic waste products. Some patients benefit from probiotic supplementation to restore healthy gut flora, particularly after intestinal parasitic infections or if gastrointestinal symptoms occur during treatment.

Regular physical activity supports overall health and immune function, though patients should adjust activity levels based on their symptoms and energy levels during acute infection and treatment. Adequate rest and sleep are crucial for immune system function and recovery. Patients experiencing fatigue during treatment should prioritize rest and gradually return to normal activity levels as symptoms improve.

Stress Management and Mental Health

Chronic parasitic infections and the associated symptoms can impact mental health and quality of life. Stress management techniques such as mindfulness meditation, deep breathing exercises, or yoga may help patients cope with treatment-related anxiety and discomfort. Addressing mental health concerns supports overall treatment adherence and recovery.

The psychological burden of parasitic infections, particularly visible conditions like scabies or chronic diseases like onchocerciasis, should not be underestimated. Patients may benefit from counseling or support groups, particularly when dealing with stigma associated with certain parasitic infections. Healthcare providers should address both physical and psychological aspects of parasitic disease management.

Preventive measures are crucial for avoiding reinfection and protecting others from transmission. For scabies, all household members and close contacts should be treated simultaneously, even if asymptomatic, to prevent transmission cycles. All bedding, clothing, and towels should be washed in hot water and dried on high heat. Items that cannot be washed should be sealed in plastic bags for at least 72 hours to kill mites.

Environmental hygiene practices help prevent reinfection with intestinal parasites. Proper handwashing before eating and after using the bathroom, avoiding contaminated water sources, thoroughly washing fruits and vegetables, and proper food preparation all reduce parasite exposure risk. In endemic areas, wearing protective footwear prevents soil-transmitted helminth infections.

For travelers to regions where parasitic infections are endemic, preventive measures include avoiding potentially contaminated food and water, using insect repellents, wearing protective clothing, and seeking pre-travel medical advice regarding prophylactic measures. Understanding local health risks and taking appropriate precautions significantly reduces infection risk.

Frequently Asked Questions

Q: How long does it take for ivermectin to work for parasitic infections?
A: The timeline for ivermectin effectiveness varies by infection type. For intestinal parasites like strongyloides, patients may notice symptom improvement within 2-3 days, though complete parasite clearance takes 1-2 weeks. For scabies, itching may initially worsen before improving, with most patients experiencing significant relief within 1-2 weeks. Onchocerciasis symptoms improve gradually over weeks to months as microfilariae are eliminated. Complete treatment evaluation requires follow-up testing as directed by your healthcare provider.

Q: Can I take ivermectin without a prescription?
A: No, ivermectin should only be used under medical supervision with a valid prescription. Proper diagnosis is essential to confirm parasitic infection and determine appropriate treatment. Self-medication risks incorrect dosing, treatment of non-parasitic conditions, missed serious diagnoses, and potential adverse effects. Healthcare providers at SafeRxPills ensure appropriate prescribing based on confirmed diagnosis and individual patient factors. Always consult a qualified healthcare professional before starting ivermectin treatment.

Q: What is the correct ivermectin dosage for my body weight?
A: Ivermectin dosing is calculated based on body weight, typically 150-200 micrograms per kilogram depending on the condition being treated. For example, a 70 kg adult treating strongyloidiasis would typically receive approximately 14 mg as a single dose (200 mcg/kg). However, precise dosing should only be determined by your healthcare provider based on accurate weight measurement, specific diagnosis, and clinical factors. Never calculate or adjust your own dose without medical guidance.

Q: Is it safe to take ivermectin if I'm pregnant or breastfeeding?
A: Ivermectin use during pregnancy and breastfeeding requires careful medical evaluation. The medication is classified as pregnancy category C, meaning animal studies show potential risks, but human data are limited. It should only be used during pregnancy when potential benefits outweigh risks, as determined by your healthcare provider. Ivermectin is excreted in breast milk in low concentrations. Discuss your pregnancy or breastfeeding status with your doctor before starting treatment to ensure appropriate decision-making regarding medication use.

Q: What should I do if I miss a dose of ivermectin?
A: If you miss a scheduled ivermectin dose in a multi-dose treatment regimen, contact your healthcare provider for guidance. For single-dose treatments, missing the dose means taking it as soon as you remember, then following up with your provider regarding any needed repeat doses. Do not double doses to make up for missed medications. The timing of doses is important for treatment effectiveness, so maintaining the prescribed schedule ensures optimal parasite elimination while minimizing resistance development.

Q: Can ivermectin be taken with other medications?
A: Ivermectin can interact with certain medications, so informing your healthcare provider about all medications, supplements, and herbal products you take is essential. Significant interactions may occur with warfarin (increased bleeding risk), certain anticonvulsants, and medications affecting the blood-brain barrier. Generally, ivermectin can be safely combined with many common medications when used as directed, but individual assessment is necessary to identify potential interactions specific to your medication regimen.

Q: How often can I take ivermectin safely?
A: The frequency of ivermectin dosing depends on the condition being treated and individual response. For most parasitic infections, single doses or short courses (1-2 doses spaced 7-14 days apart) are sufficient. For onchocerciasis control in endemic areas, dosing every 6-12 months may be recommended as part of disease prevention programs. Repeated dosing should only occur under medical supervision based on treatment response and follow-up testing. Taking ivermectin more frequently than prescribed increases adverse effect risks without additional therapeutic benefit.

Conclusion

Understanding the proper ivermectin dosage guide is fundamental to achieving safe and effective treatment of parasitic infections. This comprehensive antiparasitic medication has proven its value over decades of clinical use, offering effective treatment for various parasitic conditions when used according to established guidelines. From strongyloidiasis and onchocerciasis to scabies and other parasitic infections, ivermectin provides a reliable therapeutic option with a favorable safety profile when prescribed and monitored appropriately by healthcare professionals.

The key to successful ivermectin therapy lies in proper diagnosis, accurate weight-based dosing, and adherence to prescribed treatment regimens. While the medication is generally well-tolerated, understanding potential side effects, contraindications, and necessary precautions ensures optimal safety for all patients. The importance of medical supervision cannot be overstated—self-medication with antiparasitic drugs poses significant risks including inappropriate treatment, incorrect dosing, and potential adverse outcomes.

Complementing pharmacological treatment with appropriate lifestyle modifications, hygiene practices, and preventive measures enhances treatment success and reduces reinfection risk. Environmental controls, proper sanitation, and protective measures in endemic areas work synergistically with ivermectin therapy to break transmission cycles and prevent future infections. For patients traveling to or living in areas where parasitic infections are prevalent, understanding prevention strategies is as important as knowing treatment options.

At SafeRxPills, we are committed to providing access to quality antiparasitic medications along with comprehensive patient education and support. Our licensed pharmacy ensures that patients worldwide can access genuine ivermectin formulations with proper pharmaceutical standards and professional guidance. Whether you require ivermectin for a diagnosed parasitic infection or need expert advice about antiparasitic treatment options, our experienced team is here to support your healthcare needs.

If you have been diagnosed with a parasitic infection requiring ivermectin treatment, or if you have questions about antiparasitic medications, consult with healthcare professionals who can provide personalized guidance based on your specific situation. Proper medical care ensures accurate diagnosis, appropriate treatment selection, optimal dosing, and necessary monitoring for the best possible outcomes. Take control of your parasitic infection treatment with expert guidance and quality medications from SafeRxPills—your trusted partner in antiparasitic therapy and comprehensive pharmaceutical care.

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any medication. Dosages mentioned are general guidelines only. SafeRxPills is a licensed online pharmacy operating in compliance with applicable regulations.